Your browser doesn't support javascript.
loading
Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs.
Gutkind, Sarah; Schackman, Bruce R; Morgan, Jake R; Leff, Jared A; Agyemang, Linda; Murphy, Sean M; Akiyama, Matthew J; Norton, Brianna L; Litwin, Alain H; Linas, Benjamin P.
Afiliação
  • Gutkind S; Department of Healthcare Policy & Research, Weill Cornell Medical College, New York.
  • Schackman BR; Department of Healthcare Policy & Research, Weill Cornell Medical College, New York.
  • Morgan JR; Department of Medicine, Section of Infectious Diseases, Boston Medical Center, Massachusetts.
  • Leff JA; Department of Healthcare Policy & Research, Weill Cornell Medical College, New York.
  • Agyemang L; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Murphy SM; Department of Healthcare Policy & Research, Weill Cornell Medical College, New York.
  • Akiyama MJ; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Norton BL; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Litwin AH; Department of Medicine, University of South Carolina School of Medicine and Greenville Health System.
  • Linas BP; Clemson University School of Health Research, South Carolina.
Clin Infect Dis ; 70(7): 1397-1405, 2020 03 17.
Article em En | MEDLINE | ID: mdl-31095683
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Preparações Farmacêuticas / Hepatite C / Hepatite C Crônica Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Preparações Farmacêuticas / Hepatite C / Hepatite C Crônica Idioma: En Ano de publicação: 2020 Tipo de documento: Article